Bills Biotech Private Limited. - Due diligence report

A 360° intelligence report on Bills Biotech: trust score, financial health, credit view, compliance, directors, growth and distress signals …

2006-08-29 Ahmedabad, Gujarat Active Unlisted Active Non-Compliant
Share
BB Bills Biotech Private Limited.
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Bills Biotech — 360° Intelligence Report

Generated from MCA filings & public records
54/100
Trust Score
Moderate

Bills Biotech is assessed as Moderate with a Trust Score of 54/100. Bills Biotech is an active private limited indian non-government company incorporated in 2006, operating in the Life Sciences sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Bills Biotech Private Limited. snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
54/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
53/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.

Charges position: 2 open (9.00 cr) · 2 satisfied (17.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Idbi Bank Limited2 48.0 cr
Others2 48.0 cr
Compliance Score: 53/100 Moderate
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 1 court forum(s).
  • Delayed payments to MSME suppliers disclosed (2 disclosure(s)).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
MOHANLAL GANGARAM PATEL 01234567 Director 01/04/2018 6 yrs Approved
RANCHHODBHAI JOITARAM PATEL 01234567 Director 01/04/2018 6 yrs Approved
PINAKEEN SHANKARBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 55
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 19+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Negative net worth.
Compliance score is weak (53/100).
2 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 27.43 Lakh.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence54/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment33/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 9.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view41/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2024
Last AGM held
Annual general meeting
29 Sep 2024
Director ceased
PINAKEEN SHANKARBHAI PATEL
21 Sep 2024
Director appointed
PINAKEEN SHANKARBHAI PATEL (Director)
31 Mar 2024
Latest balance sheet
Filed with ROC
04 Nov 2019
Charge created
Others - 6.00 cr
17 Oct 2019
Charge created
Others - 3.00 cr
21 Sep 2019
Charge satisfied
Idbi Bank Limited
10 Apr 2019
Director ceased
ANIL KUMAR PANDEY
09 Dec 2016
Securities allotted
30270000 Preference Shares - 30.27 cr raised
17 Apr 2013
Director ceased
NEERAJKUMAR RANJIT SINGH
Director ceased
RAGHUVIRSINH JITENDRASINH SOLANKI
12 Mar 2012
Securities allotted
450000.00 Equity Shares - 45.00 Lakh raised
31 Jan 2012
Charge created
Idbi Bank Limited - 8.50 cr
05 Apr 2007
Director appointed
MOHANLAL GANGARAM PATEL (Director)
Director appointed
RANCHHODBHAI JOITARAM PATEL (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Medoz Pharmaceutical U24231GJ2000PTC037288 Vadodara, Gujarat, India
Apco Dye Chem Private Limited U24112UP1989PTC010945 Uttar Pradesh, Uttar Pradesh, India
Shalman Pharmaceuticals Private Limited U24231GJ1994PTC022380 Baroda, Gujarat, India
Apco Pharma Limited U74899DL1994PLC059098 New Delhi, Delhi, India
Sunglow Pharmaceuticalss Private Limited U24232PY2010PTC002407 Pondicherry, Pondicherry, India
Zenon Lifesciences Private Limited U36912GJ2015PTC082749 Sanand, Gujarat, India
Maha Avtar Health Care Private Limited U24232DL2008PTC178277 Delhi, Delhi, India
Aquigen Bio U74999PN2018PTC176298 Mulshi, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Bills Biotech before audits and certifications: compliance score 53/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Bills Biotech: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 65/100, margin trends, ownership structure and peer set for Bills Biotech - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 54/100, distress signals and MSME payment-delay disclosures - know whether Bills Biotech pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Bills Biotech - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Bills Biotech an active company?

Bills Biotech has MCA status “Active” with a compliance score of 53/100 (Moderate).

Is Bills Biotech financially healthy?

Bills Biotech has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Bills Biotech?

Its overall Trust Score is 54/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Bills Biotech?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Bills Biotech have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 2 earlier charge(s) stand satisfied.

Is Bills Biotech up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 53/100 (Moderate).

Is it risky to lend to Bills Biotech?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.